drug

D-serine solution

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

small molecule

Pre-approval / investigational in the US

Developed by University of Minnesota

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

small molecule

Indications

Investigational (via trials)

Schizophrenia Cognition Psychosis Major Depressive Disorder With Psychotic Features Schizophreniform Disorder Mental Disorders Psychotic Disorder Psychosis NOS Psychotic Disorders Schizophrenia Disorder Bipolar Disorder With Psychotic Features Schizoaffective Disorder

Trials

Cognitive Strategies in Early Psychosis 2

NCT07263022Phase 3Not Yet Recruiting

KOLs & investigators

Caroline Cellard, Ph.DKOL score 5

Sophia Vinogradov, MDKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

University of Minnesota

company

trial

Cognitive Strategies in Early Psychosis 2

PHASE3

trial

indication

Schizophrenia

indication

Cognition

indication

Psychosis

indication

Major Depressive Disorder With Psychotic Features

indication

KOL

Caroline Cellard, Ph.D

KOL score 5

person

Sophia Vinogradov, MD

KOL score 5

person